FOCUS. Female breast cancer in the elderly; Optimizing Clinical guidelines. USing clinico-pathological and molecular data. Departmentsof Surgery



Similar documents
Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group

NEOPLASMS OF KIDNEY (RENAL CELL CARCINOMA) And RENAL PELVIS (TRANSITIONAL CELL CARCINOMA)

Report series: General cancer information

Cancer research in the Midland Region the prostate and bowel cancer projects

Simplifying the measurement of co-morbidities and their influence on chemotherapy toxicity

Big Data and Oncology Care Quality Improvement in the United States

Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data

ductal carcinoma in situ (DCIS)

Understanding ductal carcinoma in situ (DCIS) and deciding about treatment

7. Prostate cancer in PSA relapse

Breast. Patient information. cancer clinical pathway

Prostate Cancer. Treatments as unique as you are

Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization N = 50

GENERAL QUESTIONS FOR YOUR DOCTOR OR NURSE. 3. Can you refer me to a breast cancer support group or counselor?

Adjuvant Therapy for Breast Cancer: Questions and Answers

La Chemioterapia Adiuvante Dose-Dense. Lo studio GIM 2. Alessandra Fabi

Analysing research on cancer prevention and survival. Diet, nutrition, physical activity and breast cancer survivors. In partnership with

The Role of Clinical Practice Guidelines, Survivorship Care Plans, and Inter-sectoral Care in Cancer Rehabilitation

Characterisation of a Palliative Care Population in a Comprehensive Cancer Centre

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Basics and limitations of adjuvant online an internet based decision tool

Breast Cancer Treatment Guidelines

SAKK Lung Cancer Group. Current activities and future projects

Electronic health records to study population health: opportunities and challenges

Breast Cancer & Treatment in ACT and Surrounding Regions QUALITY ASSURANCE PROJECT. Five-year report

Proportion of patients with invasive breast cancer in whom ER, PR and/or

No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma

Clinical Trial Design. Sponsored by Center for Cancer Research National Cancer Institute

Recommendations for the management of early breast cancer

Adjuvant Therapy Non Small Cell Lung Cancer. Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015

Understanding INTRABEAM Intraoperative Radiation Therapy for Breast Cancer A patient guide

Management of Postmenopausal Women with T1 ER+ Tumors: Options and Tradeoffs. Case Study. Surgery. Lumpectomy and Radiation

Breast Cancer Educational Program. June 5-6, 2015

L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer

Breast cancer research and a changing treatment pathway

Breast Cancer Care & Research

Breast Health Program

Audit. Process for managing outliers in breast cancer surgery. March 2005

Prostatectomy, pelvic lymphadenect. Med age 63 years Mean followup 53 months No other cancer related therapy before recurrence. Negative.

Breast cancer treatment for elderly women: a systematic review

Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors ASCO Breast Cancer Symposium Abstract 221 Rebecca L. Glaser M.D.

National Breast and Ovarian Cancer Centre and Royal Australasian College of Surgeons

October is Breast Cancer Awareness Month!

Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy

Clinical trial enrollment among older cancer patients

Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008

TITLE: Comparison of the dosimetric planning of partial breast irradiation with and without the aid of 3D virtual reality simulation (VRS) software.

Treatment Routes in Prostate Cancer Urological Cancers SSCRG

Prostate Cancer Treatment: What s Best for You?

Lung Cancer. Public Outcomes Report. Submitted by Omar A. Majid, MD

Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE

Analysis of Population Cancer Risk Factors in National Information System SVOD

Everolimus plus exemestane for second-line endocrine treatment of oestrogen receptor positive metastatic breast cancer

Improving survival and Clinical Trials Janyne Afseth Lecturer Edinburgh Napier University

Summary 1. KEY FINDINGS The Office of Technology Assessment (OTA) concludes that research has not yet been completed to determine CHAPTER

Disparities in Stage at Diagnosis, Survival, and Quality of Cancer Care in California by Source of Health Insurance

Loco-regional Recurrence

What is new in Geriatric Oncology? The geriatric perspective

BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt

Accelerated Partial Breast Irradiation (APBI) for Breast Cancer [Preauthorization Required]

There must be an appropriate administrative structure for each residency program.

Individualized breast cancer follow-up Cost-effectiveness of various programs

Goals and Objectives: Breast Cancer Service Department of Radiation Oncology

Report with statistical data from 2007

OVARIAN CANCER TREATMENT

HAVE YOU BEEN NEWLY DIAGNOSED with DCIS?

Tricia Cox on 7/18/2012 at Oncology Center. Sarah Randolf. Female

Metastatic Breast Cancer 201. Carolyn B. Hendricks, MD October 29, 2011

New Treatment Advances for Breast Cancer

SPECIALTY CASE MANAGEMENT

Measure #1 (NQF 0059): Diabetes: Hemoglobin A1c Poor Control National Quality Strategy Domain: Effective Clinical Care

La personalizzazione terapeutica: quanto influisce l età

Mesothelioma. 1. Introduction. 1.1 General Information and Aetiology

How To Use A Breast Cancer Test To Help You Choose Chemotherapy

SAMO FoROMe Post-ESMO 2013 Breast Cancer

Guide to Understanding Breast Cancer

Bristol Hospital Cancer Care Center 2015 Annual Report

Oncology Nurse Care Coordinators as. Navigators. Improving cancer disease management and the patient experience

Early mortality rate (EMR) in Acute Myeloid Leukemia (AML)

Mechanism Of Action of Palbociclib & PFS Benefit

Clinical Trials in Geriatric Oncology. Anita O Donovan Assistant Professor, Trinity College Dublin &

One of the most mature trials that examined PROCEEDINGS. Hormone Therapy in Postmenopausal Women With Breast Cancer * William J.

Impact of radiation therapy on survival in patients with triple negative breast cancer

Outcome analysis of breast cancer patients who declined evidence-based treatment

Gilberto de Lima Lopes, MD, MBA, FAMS Chief Medical and Scientific Officer, Oncoclinicas Group Asst. Prof. of Oncology, Johns Hopkins University

What is Glioblastoma? How is GBM classified according to the WHO Grading System? What risk factors pertain to GBM?

Edinburgh Breast Unit

Important Information for Women with Breast Cancer. what lumpectomy

Allegheny Health Network. Breast Care Center

Avastin in Metastatic Breast Cancer

Management of low grade glioma s: update on recent trials

Radioterapia panencefalica. Umberto Ricardi

Ductal carcinoma in situ (DCIS)

Integrating Chemotherapy and Liver Surgery for the Management of Colorectal Metastases

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

Survivorship Care Plans Guides for Living After Cancer Treatment

Primary Care Management of Colorectal Cancer

Phyllodes tumours: borderline malignant and malignant

Guidelines for Management of Renal Cancer

Transcription:

FOCUS Female breast cancer in the elderly; Optimizing Clinical guidelines USing clinico-pathological and molecular data Departmentsof Surgery Prof. - Surgery dr. van de Velde Dr. - Gerontology Liefers and Geriatrics Department of Geriatrics Prof. dr. Westendorp Dr. de Craen Dr. Kuppen Drs. de Kruijf Drs. Van de Water Ing. Sajet

FOCUS study: Female breast cancer in the elderly; Optimizing Clinical guidelines USing clinico-pathological and molecular data. FOCUS Cohort Trial data National CCCW Molecular profiling Evidence-based guidelines Patient preferences - Vorderingen - Plannen voor de toekomst

Breast cancer in the Netherlands 1. Differences between young and elderly patients 2. Changes over time Copie artikel kop

Stage at diagnosis Changes in stage distribution for 75+ (outside the screening program)

- Increase in higher T-stage - Increase in unknown T-stage Increase in unknown stage

Treatment in the Netherlands

Proportion of patients who die of the breast cancer * Decrease in proportion of patients who die of the breast cancer * Oldest elderly: 24-28% * 75+: >50% other causes of death (Observed Expected) / (Observed) * 100

Breast cancer in the Netherlands 1. Differences between young and elderly patients 2. Changes over time Submitted The Oncologist Data will be available soon.

Population-based study One of the largest population-based studies Few studies have been able to stratify within the elderly However no details

Selection Comprehensive Cancer Centre West - Female patients with breast cancer - 1999-2001 - 65 years and older 1600 females included 1997-2004 > Inclusion 4000 females

Registration form Histopathology Morfology, size, grade, TNM, etc Receptors Detection (screening / patient detected) Complications Surgery Radiotherapy Chemotherapy (CTC) Hormone therapy Comorbidity Charlson Smoking BMI Results from the blood test Geriatric parameters Follow-up Status Recurrence Treatment recurrence Treatment Surgery Radiotherapy Adjuvant treatment Unplanned change Palliative treatment

Department of Surgery GJ Liefers W van de Water CJH van de Velde Socio-economic status Department Gerontology & Geriatrics AJM de Craen RGJ Westendorp HAGA Hospital JEA Portielje Comprehensive Cancer Centre West (Leiden) & South (Eindhoven) LGM van de Geest M Aarts Submitted BCRT; results will be available soon

FOCUS study: Female breast cancer in the elderly; Optimizing Clinical guidelines USing clinico-pathological and molecular data. FOCUS Cohort National CCCW Molecular profiling Evidence-based guidelines Trial data Patient preferences Future research - No surgery (HAGA & LUMC) - Adherence to guidelines over time - Stage IV patients - International comparison

FOCUS study: Female breast cancer in the elderly; Optimizing Clinical guidelines USing clinico-pathological and molecular data. FOCUS Cohort National CCCW Trial data Drs. W. Van de Water Evidence-based guidelines Molecular profiling Patient preferences

Hormonal therapy compliance in young and old breast cancer patients W. van de Water, MD

TEAM Benelux data N=3167 Results will be available soon

Efficacy of hormonal therapy in young and old breast cancer patients W. van de Water, MD

Research questions Age specific adverse events? Age specific efficacy of hormonal therapy? Age specific competing risk of death? International TEAM database (almost 10000 patients)

Data from clinical trials EORTC 10902 Preoperative chemotherapy EORTC 10801 BCT vs Mastectomy EORTC 10854 Perioperative chemotherapy Pooled dataset n=5500 (>65 years) FIT ELDERLY EORTC 22881 Boost vs no boost BCT TEAM data

FOCUS study: Female breast cancer in the elderly; Optimizing Clinical guidelines USing clinico-pathological and molecular data. FOCUS Cohort National CCCW Trial data Evidence-based guidelines Molecular profiling Drs. E. de Kruijf Patient preferences

Aims Welke biologische factoren verschillen tussen jongere en oudere patiënten Valideren van bestaande prognostische/predictieve factoren in oudere patiënten Vinden van nieuwe prognostische/predictieve factoren in oudere patiënten Inzicht krijgen in biologische mechanismen in borstkanker in oudere patiënten om tot evidence based risico inschattingen en stratificaties van patiënten te komen

FOCUS study: Female breast cancer in the elderly; Optimizing Clinical guidelines USing clinico-pathological and molecular data. FOCUS Cohort National CCCW Trial data Evidence-based guidelines Molecular profiling Patient preferences WORK IN PROGRESS

Prospective study Combination of all data * Molecular data * Trial data * Data from cohorts Risk model - Recurrent disease - (Breast cancer related) death - Adverse events - Patient and tumor characteristics - Patient preferences Evidence based, high quality care Tailored treatment guidelines